Showing 11,721 - 11,740 results of 47,536 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((fold decrease) OR (mean decrease)) ))', query time: 1.25s Refine Results
  1. 11721
  2. 11722

    Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis by Zhixia Li (2736331)

    Published 2016
    “…Dulaglutide, exenatide long-acting release (exe_lar), liraglutide and taspoglutide had significant lowering effect when compared with sitagliptin (HbA1c<7.0%) and insulin (HbA1c<6.5%). Finally, according to SUCRAs, placebo, thiazolidinediones and albiglutide had the best decrease effect on hypoglycemia; sulphanylureas, sitagliptin and insulin decrease the incidence of treatment discontinuation most; exe_lar and dulaglutide had the highest impact on glycemic level among 13 treatments.…”
  3. 11723
  4. 11724
  5. 11725

    Changes in neuronal morphology after 150 nM sAPP-Fc added to 5DIV neurons. by Stéphanie Chasseigneaux (231744)

    Published 2011
    “…<p>Morphometric analysis 96 hours after the addition of 150 nM sAPP-Fc to 5DIV neurons shows that: (<b>A</b>) sAPP-Fc induces a significant decrease of primary dendrite number (control (Ctrl) vs sAPP-Fc: p<0.0276). …”
  6. 11726
  7. 11727
  8. 11728

    Effect of partial Glo-I inhibition by EP on LPS-induced production of TNF-α, collagen-I and α-SMA in HSC. by Marcus Hollenbach (376231)

    Published 2017
    “…Presence of LPS and treatment with low-level concentrations of MGO (indicating partial inhibition of Glo-I activity without complete enzyme inhibition) showed significant decrease of LPS-induced release of TNF-α (absence vs. presence of 10mM MGO: 371.8±22.7 vs. 60.9±11.2 pg/ml; p<0.001), collagen-I (10.0±0.3 vs. 1.8±0.5 ng/ml; p<0.001) and α-SMA (68.6±3.6 vs. 43.8±2.2 ng/ml; p<0.001) <b>(A2, B2, C2)</b>. …”
  9. 11729

    Activity of 7DW8-5 on DCs and <i>i</i>NKT cells in rhesus macaques. by Neal N. Padte (476908)

    Published 2013
    “…Each column indicates the mean value for 5 animals per group; errors bars denote SEM. * = p < 0.05 and ** = p <0.01 when compared to control group receiving AdPfCA + 0 µg 7DW8-5. …”
  10. 11730

    Anatomical confirmation of drug injection sites. by Diana Amorim (662998)

    Published 2015
    “…Limb withdrawal threshold is presented as mean + SEM. (**<i>P</i><0.01, t-test for paired data). gf—gram force.…”
  11. 11731

    Diannexin (DA5) reduces leukocyte influx 3 days after I/R. by Kimberley E. Wever (180536)

    Published 2011
    “…(C) When compared to vehicle-treated mice, leukocyte influx in renal tissue of DA5-treated mice was decreased on day 3 after IRI induction. …”
  12. 11732

    Intra- & Inter-assay Variance for the flow cytometric analysis of STAT5Ptyr in human peripheral blood monocytes. by Erin Garrigan (473998)

    Published 2013
    “…However, this significant difference decreased to 5.4-fold at 48 hr (*p = 0.013), due to the increased inter-assay variability seen in control samples after storage.…”
  13. 11733
  14. 11734
  15. 11735
  16. 11736
  17. 11737

    Both WD and AD shift OD in the binocular V1 in fully adult mice. by Manuel Teichert (6443960)

    Published 2019
    “…<p>(<b>a, b</b>) V1 activity evoked by visual stimulation of the contra or ipsilateral eye in untreated control mice (n = 5) remained unchanged at 0, 3 and 7 days. …”
  18. 11738
  19. 11739

    Attenuation of CDK expression and cyclin D-CDK4/6 activity by androgen in PC3-Lenti-AR. by Young-Chae Kim (163381)

    Published 2015
    “…(E) In comparison to control samples, DHT treatment for 24 hours significantly decreased CDK4 and CDK6 mRNAs and pre-mRNAs 1.5 fold or more and increased CDKN1A mRNA and pre-mRNA 2 fold or more, suggesting AR-mediated regulation of transcription at these genes, n = 3. …”
  20. 11740